Bridget E. Bunner

Array ( [id] => 6007083 [patent_doc_number] => 20110059114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/851482 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13125 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059114.pdf [firstpage_image] =>[orig_patent_app_number] => 12851482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220811 [patent_doc_number] => 20120135011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Method for in vivo expansion of T regulatory cells' [patent_app_type] => utility [patent_app_number] => 13/388722 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209975 [patent_doc_number] => 20120129189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Methods of Controlling Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 13/383819 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29052 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129189.pdf [firstpage_image] =>[orig_patent_app_number] => 13383819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264731 [patent_doc_number] => 20120164159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/382044 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 29006 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10050824 [patent_doc_number] => 09090690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Anti Notch-1 antibodies' [patent_app_type] => utility [patent_app_number] => 13/378791 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 27042 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254411 [patent_doc_number] => 08617822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Method of inhibiting binding or activity of MIF by administering a MIF antagonist' [patent_app_type] => utility [patent_app_number] => 12/781546 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 6989 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12781546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197029 [patent_doc_number] => 20120121588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'MODULATION OF PILR RECEPTORS TO TREAT SEPSIS' [patent_app_type] => utility [patent_app_number] => 13/321406 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18536 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121588.pdf [firstpage_image] =>[orig_patent_app_number] => 13321406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822295 [patent_doc_number] => 20130123340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY' [patent_app_type] => utility [patent_app_number] => 13/697365 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 32105 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476013 [patent_doc_number] => 20100284986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MIGRAINES' [patent_app_type] => utility [patent_app_number] => 12/774536 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2127 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284986.pdf [firstpage_image] =>[orig_patent_app_number] => 12774536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134450 [patent_doc_number] => 20110008352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Toll-Like Receptor 3 Antagonists' [patent_app_type] => utility [patent_app_number] => 12/770147 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34773 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008352.pdf [firstpage_image] =>[orig_patent_app_number] => 12770147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392480 [patent_doc_number] => 20100303867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => ' A COMPOSITION COMPRISING A NOTCH LIGAND AND AN ALLERGENB OR ALLERGEN BYSTANDER ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/766738 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 47887 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303867.pdf [firstpage_image] =>[orig_patent_app_number] => 12766738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608225 [patent_doc_number] => 08785392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein' [patent_app_type] => utility [patent_app_number] => 13/142818 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 8185 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952451 [patent_doc_number] => 20110033481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/758540 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 61102 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033481.pdf [firstpage_image] =>[orig_patent_app_number] => 12758540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125361 [patent_doc_number] => 20110086020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 12/798027 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6041 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086020.pdf [firstpage_image] =>[orig_patent_app_number] => 12798027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9008933 [patent_doc_number] => 08524227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Anti-IL-TIF antibodies' [patent_app_type] => utility [patent_app_number] => 12/732116 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 65125 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12732116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097431 [patent_doc_number] => 20110003743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/726468 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16583 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003743.pdf [firstpage_image] =>[orig_patent_app_number] => 12726468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097431 [patent_doc_number] => 20110003743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/726468 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16583 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003743.pdf [firstpage_image] =>[orig_patent_app_number] => 12726468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783902 [patent_doc_number] => 20120045458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'USE OF NOTCH REGULATORS FOR MODULATING THE IMMUNE RESPONSE BY INDUCTION/SUPPRESSION OF INTERLEUKIN-22' [patent_app_type] => utility [patent_app_number] => 13/201638 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3883 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045458.pdf [firstpage_image] =>[orig_patent_app_number] => 13201638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644576 [patent_doc_number] => 08022182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Truncated BAFF receptors' [patent_app_type] => utility [patent_app_number] => 12/704190 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 11584 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022182.pdf [firstpage_image] =>[orig_patent_app_number] => 12704190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732335 [patent_doc_number] => 20120015352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD OF DETERMINING SENSITIVITY OF HUMAN OR NON-HUMAN ANIMAL CELLS TO AN IAP ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 13/146817 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15390 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015352.pdf [firstpage_image] =>[orig_patent_app_number] => 13146817 [rel_patent_id] =>[rel_patent_doc_number] =>)